Amaia
Vilas Zornoza
Investigadora ata 2022
Hospital Universitario Reina Sofia
Córdoba, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Reina Sofia (9)
2012
-
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia
Leukemia, Vol. 26, Núm. 7, pp. 1517-1526
2011
-
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family
British Journal of Haematology, Vol. 155, Núm. 1, pp. 73-83
-
Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in Acute Lymphoblastic Leukemia
PLoS ONE, Vol. 6, Núm. 2
2010
-
Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia
Cancer Science, Vol. 101, Núm. 2, pp. 425-432
2009
-
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia
Cancer Research, Vol. 69, Núm. 10, pp. 4443-4453
-
MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
Molecular Cancer, Vol. 8, pp. 69
2008
-
Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth
Molecular Cancer Research, Vol. 6, Núm. 12, pp. 1830-1840
-
Methylation status of Wnt signaling pathway genes affects the clinical outcome of Philadelphia-positive acute lymphoblastic leukemia
Cancer Science, Vol. 99, Núm. 9, pp. 1865-1868
2007
-
WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia
European Journal of Cancer, Vol. 43, Núm. 18, pp. 2736-2746